Suchergebnisse - "Naro, Chiara"

PubPharm (38)

1

Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von Naro, C. | Antonioni, A. | Medici, V. | +6

2

Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

enthalten in: Journal of experimental & clinical cancer research | 2024

von Naro, C. | Antonioni, A. | Medici, V. | +6

3

An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer

enthalten in: Cell reports. Medicine | 2024

von Ruta, V. | Naro, C. | Pieraccioli, M. | +18

4

Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3

enthalten in: Cancer communications (London, England) | 2024

von Cesaro, B. | Iaiza, A. | Piscopo, F. | +15

5

Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development

enthalten in: Nucleic acids research | 2024

von Cesari, E. | Farini, D. | Medici, V. | +15

6

Purification by STA-PUT Technique of Male Germ Cells from Single Mouse and RNA-Extraction for Transcriptomic Analysis

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2024

von Naro, C. | Sette, C. | Geremia, R.

7

Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment

enthalten in: Molecules (Basel, Switzerland) | 2023

von Masci, D. | Naro, C. | Puxeddu, M. | +4

8

Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent

enthalten in: ACS pharmacology & translational science | 2023

von Nalli, M. | Di Magno, L. | Wen, Y. | +26

9

Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer

enthalten in: Frontiers in oncology | 2022

von Naro, C. | Barbagallo, F. | Caggiano, C. | +5

10

Editorial : Insight in cancer genetics: 2022

enthalten in: Frontiers in oncology | 2022

von Naro, C. | Cunliffe, H. | Sette, C.